Transcription of HIGHLIGHTS OF PRESCRIBING INFORMATION …
{{id}} {{{paragraph}}}
Example: marketing
HIGHLIGHTS OF PRESCRIBING INFORMATION …
HIGHLIGHTS OF PRESCRIBING INFORMATION . _____. These HIGHLIGHTS do not include all the INFORMATION needed WARNINGS AND PRECAUTIONS_____. to use latisse safely and effectively. See full Concurrent administration of latisse and PRESCRIBING INFORMATION for latisse . intraocular pressure (IOP)-lowering prostaglandin analogs in ocular hypertensive patients may latisse (bimatoprost ophthalmic solution) decrease the IOP-lowering effect. Patients using Initial Approval: 2001 these products concomitantly should be closely monitored for changes to their IOP. ( ). _____. INDICATIONS AND USAGE_____.. latisse is a prostaglandin analog, indicated to treat Pigmentation of the eyelids and iris may occur. hypotrichosis of the eyelashes by increasing their growth Iris pigmentation is likely to be permanent.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LATISSE ®
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: